The significance of left ventricular ejection time in heart failure with reduced ejection fraction

被引:28
|
作者
Alhakak, Alia S. [1 ]
Teerlink, John R. [2 ,3 ]
Lindenfeld, Joann [4 ]
Boehm, Michael [5 ]
Rosano, Giuseppe M. C. [6 ]
Biering-Sorensen, Tor [7 ]
机构
[1] Univ Copenhagen, Herlev & Gentofte Hosp, Dept Cardiol, Copenhagen, Denmark
[2] Univ Calif San Francisco, San Francisco Vet Affairs Med Ctr, Sect Cardiol, San Francisco, CA 94143 USA
[3] Univ Calif San Francisco, Sch Med, San Francisco, CA USA
[4] Vanderbilt Univ, Med Ctr, Nashville, TN USA
[5] Saarland Univ, Univ Klinikum Saarlandes, Klin Innere Med 3, Dept Internal Med, Homburg, Germany
[6] IRCCS San Raffaele Pisana, Dept Med Sci, Rome, Italy
[7] Univ Copenhagen, Fac Hlth & Med Sci, Dept Biomed Sci, Copenhagen, Denmark
关键词
Left ventricular ejection time; Heart failure; Myotropes; Contractility; Outcomes; CARDIAC MYOSIN ACTIVATOR; MYOCARDIAL PERFORMANCE INDEX; M-MODE ECHOCARDIOGRAPHY; IMAGING M-MODE; OMECAMTIV MECARBIL; INCREASE CONTRACTILITY; INTERVALS; MECHANISMS; RISK; CARVEDILOL;
D O I
10.1002/ejhf.2125
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Left ventricular ejection time (LVET) is defined as the time interval from aortic valve opening to aortic valve closure, and is the phase of systole during which the left ventricle ejects blood into the aorta. LVET has been used for several decades to assess left ventricular function and contractility. However, there is a recent interest in LVET as a measure of therapeutic action for novel drugs in patients with heart failure with reduced ejection fraction (HFrEF), since LVET is shortened in these patients. This review provides an overview of the available information on LVET including methods of measuring LVET, mechanistic understanding of LVET, association of LVET with outcomes, mechanisms behind shortened LVET in HFrEF and the potential implications of drugs that affect and normalize LVET. [GRAPHICS]
引用
收藏
页码:541 / 551
页数:11
相关论文
共 50 条
  • [31] Recovered Left Ventricular Ejection Fraction and Its Prognostic Impacts in Hospitalized Heart Failure Patients with Reduced Ejection Fraction
    Abe, Satoshi
    Yoshihisa, Akiomi
    Ichijo, Yasuhiro
    Sato, Yu
    Kanno, Yuki
    Takiguchi, Mai
    Yokokawa, Tetsuro
    Misaka, Tomofumi
    Sato, Takamasa
    Oikawa, Masayoshi
    Kobayashi, Atsushi
    Yamaki, Takayoshi
    Kunii, Hiroyuki
    Takeishi, Yasuchika
    INTERNATIONAL HEART JOURNAL, 2020, 61 (02) : 281 - 288
  • [32] HEART FAILURE WITH INTERMEDIATE LEFT VENTRICULAR EJECTION FRACTION
    Gwag, Hye Bin
    Lee, Ga Yeon
    Kim, Minsun
    Kang, Jiseok
    Choi, Jin-Oh
    Jeon, Eun-Seok
    Choi, Dong-Ju
    Kim, Jae-Joong
    Hwang, Kyung-Kook
    Chae, Shung Chull
    Back, Sang Hong
    Yoo, Byung-Su
    Cho, Myeong-Chan
    Oh, Byung-Hee
    Kang, Seok-Min
    Park, Hyun-Young
    Ahn, Young Keun
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 67 (13) : 1482 - 1482
  • [33] Transition of Left Ventricular Ejection Fraction in Heart Failure
    Sakata, Yasuhiko
    Tsuji, Kanako
    Nochioka, Kotaro
    Shimokawa, Hiroaki
    HEART FAILURE: FROM RESEARCH TO CLINICAL PRACTICE, VOL 3, 2018, 1067 : 5 - 15
  • [34] Predictors of Left Ventricular Ejection Fraction Improvement in Patients with Early-Stage Heart Failure with Reduced Ejection Fraction
    Ho, Li-Ting
    Juang, Jyh-Ming Jimmy
    Chen, Ying-Hsien
    Chen, Yih-Sharng
    Hsu, Ron-Bin
    Huang, Ching-Chang
    Lee, Chii-Ming
    Chien, Kuo-Liong
    ACTA CARDIOLOGICA SINICA, 2023, 39 (06) : 854 - 861
  • [35] Determinants and prognostic implication of improved left ventricular ejection fraction in chronic heart failure patients with reduced ejection fraction
    Hu, K.
    Schregelmann, L.
    Liu, D.
    Lengenfelder, B.
    Ertl, G.
    Frantz, S.
    Nordbeck, P.
    EUROPEAN HEART JOURNAL, 2020, 41 : 955 - 955
  • [36] Heart failure with intermediate left ventricular ejection fraction
    Lee, G. Y. Ga Yeon
    Jeon, E. S.
    Choi, J. O.
    EUROPEAN JOURNAL OF HEART FAILURE, 2015, 17 : 154 - 155
  • [37] Left ventricular ejection fraction recovery in patients with heart failure with reduced ejection fraction treated with sacubitril/valsartan.
    Diez Villanueva, P.
    De la Cuerda, F.
    Vicent, L.
    Esteban-Fernandez, A.
    Gomez-Bueno, M.
    De Juan, J.
    Iniesta, A. M.
    Ayesta, A.
    Rojas, A.
    Bover, R.
    Iglesias, D.
    Garcia Aguado, M.
    Perea Egido, J. A.
    Salamanca, J.
    Martinez-Selles, M.
    EUROPEAN JOURNAL OF HEART FAILURE, 2019, 21 : 206 - 207
  • [38] LEFT VENTRICULAR SYSTOLIC EJECTION TIME IS AN INDEPENDENT PREDICTOR OF ALL-CAUSE MORTALITY IN HEART FAILURE WITH REDUCED EJECTION FRACTION
    Alhakak, Alia Saed
    Sengelov, Morten
    Jorgensen, Peter
    Bruun, Niels Eske
    Abildgaard, Ulrik
    Iversen, Allan
    Hansen, Thomas Fritz
    Teerlink, John
    Malik, Fady
    Solomon, Scott D.
    Gislason, Gunnar
    Biering-Sorensen, Tor
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (11) : 1776 - 1776
  • [39] Left ventricular systolic ejection time is an independent predictor of all-cause mortality in heart failure with reduced ejection fraction
    Alhakak, Alia S.
    Sengelov, Morten
    Jorgensen, Peter G.
    Bruun, Niels E.
    Johnsen, Cecilie
    Abildgaard, Ulrik
    Iversen, Allan Z.
    Hansen, Thomas F.
    Teerlink, John R.
    Malik, Fady I.
    Solomon, Scott D.
    Gislason, Gunnar
    Biering-Sorensen, Tor
    EUROPEAN JOURNAL OF HEART FAILURE, 2021, 23 (02) : 240 - 249
  • [40] Predictors and prognostic implications of left ventricular ejection fraction trajectory improvement in the spectrum of heart failure with reduced and mildly reduced ejection fraction
    Si, Jinping
    Ding, Zijie
    Hu, Yuze
    Zhang, Xinxin
    Zhang, Yanli
    Cao, Huajun
    Liu, Ying
    JOURNAL OF CARDIOLOGY, 2024, 83 (04) : 250 - 257